| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2021 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST STE 3700 | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC2GM132005 | Establishing Drosophila melanogaster as a model for determining gene-environment interactions that confer risk of autism using bisphenols and the autism risk gene, fragile x mental retardation 1 | 000 | 3 | NIH | 11/26/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $1,194,411 ) |
| | 2024 | 2024 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST STE 3700 | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 000 | 8 | NIH | 7/29/2024 | $106,500 |
| | 2024 | 2024 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST STE 3700 | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R21DC020274 | Objective and noninvasive diagnosis of middle-ear and conductive pathologies using simulation-based inference and transfer learning applied to clinical data | 000 | 4 | NIH | 4/26/2024 | $177,500 |
| | 2024 | 2024 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST STE 3700 | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R16GM145435 | Development of phenolic small molecule inhibitors of PfATP6, a Plasmodium calcium ATPase | 000 | 2 | NIH | 5/17/2024 | $142,000 |
| | 2024 | 2024 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST STE 3700 | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R16GM145435 | Development of phenolic small molecule inhibitors of PfATP6, a Plasmodium calcium ATPase | 001 | 2 | NIH | 6/19/2024 | $76,201 |
| | 2024 | 2024 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST STE 3700 | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R15ES036345 | Establishing Drosophila melanogaster as a model for developmental neurotoxicity assessment of air pollutants using diesel exhaust | 001 | 1 | NIH | 8/7/2024 | $0 |
| | 2024 | 2024 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST STE 3700 | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R15ES036345 | Establishing Drosophila melanogaster as a model for developmental neurotoxicity assessment of air pollutants using diesel exhaust | 000 | 1 | NIH | 6/13/2024 | $421,705 |
| | 2024 | 2024 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST STE 3700 | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | T34GM153398 | U-RISE at Sacramento State | 000 | 1 | NIH | 3/21/2024 | $270,505 |
|
| Issue Date FY: 2023 ( Subtotal = $511,247 ) |
| | 2023 | 2023 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST STE 3700 | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 002 | 7 | NIH | 8/17/2023 | $106,500 |
| | 2023 | 2023 | UNIVERSITY ENTERPRISES INC | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R21DC020274 | Objective and noninvasive diagnosis of middle-ear and conductive pathologies using simulation-based inference and transfer learning applied to clinical data | 002 | 3 | NIH | 5/10/2023 | $177,500 |
| | 2023 | 2023 | UNIVERSITY ENTERPRISES INC | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R16GM145435 | Development of phenolic small molecule inhibitors of PfATP6, a Plasmodium calcium ATPase | 000 | 1 | NIH | 4/27/2023 | $142,000 |
| | 2023 | 2022 | UNIVERSITY ENTERPRISES INC | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R21DC020274 | Objective and noninvasive diagnosis of middle-ear and conductive pathologies using simulation-based inference and transfer learning applied to clinical data | 001 | 2 | NIH | 1/20/2023 | $85,247 |
| | 2023 | 2021 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST STE 3700 | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 001 | 5 | NIH | 4/7/2023 | -$24,829 |
| | 2023 | 2021 | UNIVERSITY ENTERPRISES INC | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R25GM122667 | Sacramento State RISE Program | 000 | 5 | NIH | 6/26/2023 | $0 |
| | 2023 | 2021 | UNIVERSITY ENTERPRISES INC | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R25GM122667 | Sacramento State RISE Program | 001 | 5 | NIH | 6/27/2023 | $0 |
| | 2023 | 2021 | UNIVERSITY ENTERPRISES INC | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R25GM122667 | Sacramento State RISE Program | 002 | 5 | NIH | 6/29/2023 | $0 |
| | 2023 | 2021 | UNIVERSITY ENTERPRISES INC | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC2GM132005 | Establishing Drosophila melanogaster as a model for determining gene-environment interactions that confer risk of autism using bisphenols and the autism risk gene, fragile x mental retardation 1 | 000 | 3 | NIH | 6/2/2023 | $0 |
| | 2023 | 2019 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST STE 3700 | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 000 | 4 | NIH | 4/7/2023 | $24,829 |
|
| Issue Date FY: 2022 ( Subtotal = $106,500 ) |
| | 2022 | 2022 | UNIVERSITY ENTERPRISES INC | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 002 | 6 | NIH | 8/15/2022 | $106,500 |
| | 2022 | 2021 | UNIVERSITY ENTERPRISES INC | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 001 | 5 | NIH | 5/19/2022 | $64,031 |
| | 2022 | 2021 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R25GM122667 | Sacramento State RISE Program | 001 | 5 | NIH | 1/28/2022 | $0 |
| | 2022 | 2021 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R25GM122667 | Sacramento State RISE Program | 000 | 5 | NIH | 1/27/2022 | $0 |
| | 2022 | 2019 | UNIVERSITY ENTERPRISES INC | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 000 | 4 | NIH | 5/19/2022 | -$64,031 |
|
| Issue Date FY: 2021 ( Subtotal = $465,498 ) |
| | 2021 | 2021 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R25GM122667 | Sacramento State RISE Program | 000 | 5 | NIH | 7/29/2021 | $133,202 |
| | 2021 | 2021 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R25GM122667 | Sacramento State RISE Program | 002 | 5 | NIH | 9/1/2021 | $83,796 |
| | 2021 | 2021 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R25GM122667 | Sacramento State RISE Program | 001 | 5 | NIH | 8/26/2021 | $0 |
| | 2021 | 2021 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC2GM132005 | Establishing Drosophila melanogaster as a model for determining gene-environment interactions that confer risk of autism using bisphenols and the autism risk gene, fragile x mental retardation 1 | 000 | 3 | NIH | 5/20/2021 | $142,000 |
| | 2021 | 2021 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 002 | 5 | NIH | 9/20/2021 | $106,500 |
| | 2021 | 2019 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 000 | 4 | NIH | 2/25/2021 | $0 |
| | 2021 | 2019 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 001 | 4 | NIH | 9/20/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $438,060 ) |
| | 2020 | 2020 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R25GM122667 | Sacramento State RISE Program | 000 | 4 | NIH | 7/22/2020 | $296,060 |
| | 2020 | 2020 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC2GM132005 | Establishing Drosophila melanogaster as a model for determining gene-environment interactions that confer risk of autism using bisphenols and the autism risk gene, fragile x mental retardation 1 | 000 | 2 | NIH | 5/19/2020 | $142,000 |
| | 2020 | 2019 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 000 | 4 | NIH | 5/12/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $532,345 ) |
| | 2019 | 2019 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC2GM132005 | Establishing Drosophila melanogaster as a model for determining gene-environment interactions that confer risk of autism using bisphenols and the autism risk gene, fragile x mental retardation 1 | 000 | 1 | NIH | 6/10/2019 | $142,000 |
| | 2019 | 2019 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 000 | 4 | NIH | 3/20/2019 | $106,500 |
| | 2019 | 2019 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R25GM122667 | Sacramento State RISE Program | 000 | 3 | NIH | 7/24/2019 | $283,845 |
|
| Issue Date FY: 2018 ( Subtotal = $383,994 ) |
| | 2018 | 2018 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 001 | 3 | NIH | 5/11/2018 | $10,650 |
| | 2018 | 2018 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 000 | 3 | NIH | 3/9/2018 | $95,850 |
| | 2018 | 2018 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R25GM122667 | Sacramento State RISE Program | 000 | 2 | NIH | 7/23/2018 | $277,494 |
|
| Issue Date FY: 2017 ( Subtotal = $201,044 ) (Continued on the next page) |
| | 2017 | 2017 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | SC3GM119521 | Glycopolymer Inhibitors of Heparan Sulfate Proteoglycan Binding Pathogens | 000 | 2 | NIH | 3/30/2017 | $95,681 |
| | 2017 | 2017 | UNIVERSITY ENTERPRISES, INC. | 6000 J ST | SACRAMENTO | CA | 95819-2605 | SACRAMENTO | USA | R25GM122667 | Sacramento State RISE Program | 000 | 1 | NIH | 7/26/2017 | $201,063 |
|
